Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02802930 · ClinicalTrials.gov registry record · NA
Test the Phototoxicity of Sunscreen Products
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02802930: Completed NA study, sponsored by Bayer.
NCT02802930 is a NA study that has completed, run by Bayer. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02802930, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The primary objective of this study was to evaluate the potential for phototoxicity of the sun care products SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 compared to that of a negative control (0.9% sodium chloride \[NaCl\]) after a single 24 h application of test materials followed by irradiation with ultraviolet A (UVA) and ultraviolet B (UVB). The secondary objective of this study was to evaluate the safety of the sun care products SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 combined with UVA/B irradiation by monitoring adverse events (AEs) throughout the study.
Primary Outcome
Skin irritation was rated on a scale from 0-7 where 0 is no evidence of irritation and 7 is strong reaction spreading beyond test site
Interventions
- DRUG SPF 50 Y65 110 (BAY987519)
- DRUG SPF 50 Y51 002 (BAY987519)
- DRUG SPF 15 V27 104 (BAY987519)
- DRUG Sodium chloride [NaCl]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-04-20 |
| Est. Completion | 2015-04-26 |
| Phase | NA |
What the finished NCT02802930 record still lists
NCT02802930 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which SPF 50 Y65 110 (BAY987519) is the first listed.
NCT02802930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02802930 about?
NCT02802930 is a clinical study titled "Test the Phototoxicity of Sunscreen Products". The primary objective of this study was to evaluate the potential for phototoxicity of the sun care products SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 compared to that of a negative control (0.9% sodium chloride \[NaCl\]) after a single 24 h application of test materials followed by irradia...
What is the current status of trial NCT02802930?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2015-04-20. Estimated completion is 2015-04-26.
What interventions are being tested in trial NCT02802930?
The interventions under investigation include: SPF 50 Y65 110 (BAY987519) (DRUG), SPF 50 Y51 002 (BAY987519) (DRUG), SPF 15 V27 104 (BAY987519) (DRUG), Sodium chloride [NaCl] (DRUG).
Who is sponsoring clinical trial NCT02802930?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02802930's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI